Evidence map›Paper›PMID 22349151›Full record

ArticleSocial psychiatry and psychiatric epidemiology2012

Psychotherapy use in a privately insured population of patients diagnosed with a mental disorder.

Ilan Harpaz-Rotem, Daniel Libby, Robert A Rosenheck

Abstract read
PubMed Publisher
In one paragraph

Article in Social psychiatry and psychiatric epidemiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Extent and Predictors of Potentially Inappropriate Antidepressant Use Among Older Adults With Dementia and Major Depressive Disorder.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2019
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Ilan Harpaz-RotemDepartment of Psychiatry, Yale School of Medicine, New Haven, USA. ilan.harpaz-rotem@yale.edu
Daniel Libby
Robert A Rosenheck
Yale University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAlthough there is growing evidence demonstrating the effectiveness of psychotherapy in the treatment of mental disorders, the use of psychotherapy in privately insured populations has not been examined. This study examines utilization rates and correlates of the receipt of psychotherapy.

methodsA large claims database of US private sector claims was used to examine utilization rates and correlates of receipt of psychotherapy. Altogether, 860,090 adults who received mental health services in 2005 were identified from the database. Multivariate binary regression and general linear models were used to assess the association of patient characteristics with use of psychotherapy, use of group or family therapy and the number of psychotherapy visits based on current procedural terminology (CPT) codes.

resultsOnly 32.4% of patients diagnosed with a mental illness received CPT codes indicating receipt of psychotherapy, and of these 96.5% received individual psychotherapy. Almost 75% of individuals diagnosed with posttraumatic stress disorder, 62% with major depressive disorder, and 54% with bipolar disorder received psychotherapy. Larger numbers of psychotherapy visits were associated with posttraumatic stress disorder (PTSD), alcohol use and mild depression. Larger numbers of psychotherapy visits were associated with PTSD, alcohol use and mild depression. Drug use, schizophrenia, bipolar disorder and major depressive disorder (MDD) were associated with fewer psychotherapy visits.

conclusionsSubstantial differences in use of psychotherapy were observed across diagnoses, perhaps reflecting the availability of alternative drug therapies. Greater use of psychotherapy in patients with PTSD may reflect weaker evidence of the effectiveness of pharmacological treatment, while less use in MDD may reflect greater evidence of drug benefits.

Indexed as

Insurance, HealthPrivate SectorAdultAnxiety DisordersComorbidityDatabases as TopicFemaleHealth Care SurveysHumansInsurance CoverageLogistic ModelsMajor Depressive DisorderMaleMental DisordersMental Health ServicesMiddle Aged

Identifiers

PMID22349151
OpenAlexW1969152765

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.